Oncogene - Table of Contents alert Volume 31 Issue 45

TABLE OF CONTENTS Volume 31, Issue 45 (November 2012) In this issue Review Original Articles Short Communications Corrigendum Also new AOP Sign up for e-alerts Recommend to your library Web feed Subscribe Advertisement Cancer Genome Summit 4-6 Dec '12 | Boston Gain exclusive information and expert insights from all cancer genome stakeholders in order to optimize drug development, further personalized medicine and improve patient outcomes This meeting will show you how to identify new drug targets, combat resistance mechanisms, streamline clinical trials and improve clinical management www.cancergenome-summit.com   Review Top P53-induced protein with a death domain (PIDD): master of puppets? F J Bock, L Peintner, M Tanzer, C Manzl and A Villunger Oncogene 2012 31: 4733-4739; advance online publication, January 23, 2012; 10.1038/onc.2011.639 Abstract | Full Text Original Articles Top RhoA triggers a specific signaling pathway that generates transforming microvesicles in cancer cells B Li, M A Antonyak, J Zhang and R A Cerione Oncogene 2012 31: 4740-4749; advance online publication, January 23, 2012; 10.1038/onc.2011.636 Abstract | Full Text Scavenging of CXCL12 by CXCR7 promotes tumor growth and metastasis of CXCR4-positive breast cancer cells K E Luker, S A Lewin, L A Mihalko, B T Schmidt, J S Winkler, N L Coggins, D G Thomas and G D Luker Oncogene 2012 31: 4750-4758; advance online publication, January 23, 2012; 10.1038/onc.2011.633 Abstract | Full Text AR intragenic deletions linked to androgen receptor splice variant expression and activity in models of prostate cancer progression Y Li, T H Hwang, L A Oseth, A Hauge, R L Vessella, S C Schmechel, B Hirsch, K B Beckman, K A Silverstein and S M Dehm Oncogene 2012 31: 4759-4767; advance online publication, January 23, 2012; 10.1038/onc.2011.637 Abstract | Full Text Molecular mechanisms for the regulation of Nrf2-mediated cell proliferation in non-small-cell lung cancers T Yamadori, Y Ishii, S Homma, Y Morishima, K Kurishima, K Itoh, M Yamamoto, Y Minami, M Noguchi and N Hizawa Oncogene 2012 31: 4768-4777; advance online publication, January 16, 2012; 10.1038/onc.2011.628 Abstract | Full Text ETV5 cooperates with LPP as a sensor of extracellular signals and promotes EMT in endometrial carcinomas E Colas, L Muinelo-Romay, L Alonso-Alconada, M Llaurado, M Monge, J Barbazan, M Gonzalez, M Schoumacher, N Pedrola, T Ertekin, L Devis, A Ruiz, J Castellvi, A Doll, A Gil-Moreno, M Vazquez-Levin, L Lapyckyj, R Lopez-Lopez, S Robine, E Friederich, M Castro, J Reventos, D Vignjevic and M Abal Oncogene 2012 31: 4778-4788; advance online publication, January 23, 2012; 10.1038/onc.2011.632 Abstract | Full Text Functional analysis and consequences of Mdm2 E3 ligase inhibition in human tumor cells M Wade, Y C Li, A S Matani, S M G Braun, F Milanesi, L W Rodewald and G M Wahl Oncogene 2012 31: 4789-4797; advance online publication, January 23, 2012; 10.1038/onc.2011.625 Abstract | Full Text Short Communications Top FOXC1 regulates the functions of human basal-like breast cancer cells by activating NF-κB signaling J Wang, P S Ray, M-S Sim, X Z Zhou, K P Lu, A V Lee, X Lin, S P Bagaria, A E Giuliano and X Cui Oncogene 2012 31: 4798-4802; advance online publication, January 16, 2012; 10.1038/onc.2011.635 Abstract | Full Text The nucleoporin 153, a novel factor in double-strand break repair and DNA damage response C Lemaître, B Fischer, A Kalousi, A-S Hoffbeck, J Guirouilh-Barbat, O D Shahar, D Genet, M Goldberg, P Betrand, B Lopez, L Brino and E Soutoglou Oncogene 2012 31: 4803-4809; advance online publication, January 16, 2012; 10.1038/onc.2011.638 Abstract | Full Text Corrigendum Top Development of a Listeria monocytogenes-based vaccine against hepatocellular carcinoma Y Chen, D Yang, S Li, Y Gao, R Jiang, L Deng, F R Frankel and B Sun Oncogene 2012 31: 4810; 10.1038/onc.2012.430 Full Text Advertisement Call for papers! Submit your best work in cancer research, including mechanisms of cellular oncogene activation, structure and function of encoded proteins, DNA and RNA tumor viruses and all other aspects of oncogene structure and function. Our online submission process is easy and can assist you in becoming part of this distinguished journal. Visit our Author page to learn about the benefits of publishing in the Journal and for guidelines on how to submit your paper.   Natureevents is a fully searchable, multi-disciplinary database designed to maximise exposure for events organisers. The contents of the Natureevents Directory are now live. The digital version is available here. Find the latest scientific conferences, courses, meetings and symposia on natureevents.com. For event advertising opportunities across the Nature Publishing Group portfolio please contact natureevents@nature.com More Nature Events Please note that you need to be a subscriber or site-licence holder to enjoy full-text access to Oncogene. In order to do so, please purchase a subscription. You have been sent this Table of Contents Alert because you have opted in to receive it. You can change or discontinue your e-mail alerts at any time, by modifying your preferences on your nature.com account at: www.nature.com/nams/svc/myaccount (You will need to log in to be recognised as a nature.com registrant). For further technical assistance, please contact our registration department. For print subscription enquiries, please contact our subscription department. For other enquiries, please contact our customer feedback department. Nature Publishing Group | 75 Varick Street, 9th Floor | New York | NY 10013-1917 | USA Nature Publishing Group's worldwide offices: London - Paris - Munich - New Delhi - Tokyo - Melbourne San Diego - San Francisco - Washington - New York - Boston Macmillan Publishers Limited is a company incorporated in England and Wales under company number 785998 and whose registered office is located at Brunel Road, Houndmills, Basingstoke, Hampshire RG21 6XS. © 2012 Nature Publishing Group, a division of Macmillan Publishers Limited. All Rights Reserved.